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ABSTRACT
Introduction Singing for lung health (SLH) is a 
popular arts- in- health activity for people with long- 
term respiratory conditions. Participants report 
biopsychosocial benefits, however, research on 
impact is limited. The ‘SLH: Improving Experiences of 
Lung Disease trial’, a randomised controlled, single 
(assessor) blind, trial of 12 weeks SLH versus usual 
care for people with chronic obstructive pulmonary 
disease (COPD) (n=120) was setup to help to address 
this. The first group (n=18, nine singing and nine 
controls) started face- to- face (five sessions) before 
changing to online delivery (seven sessions) due to 
COVID-19- related physical distancing measures. As 
such, the experience of this group is here reported as a 
pilot study to inform further research in this area.
Methods We conducted semistructured interviews 
and thematic analysis regarding barriers, facilitators 
and key considerations for transitioning from face- 
to- face to online delivery. Pilot quantitative outcomes 
include attendance, premeasures and postmeasures of 
quality of life and disease impact (Short Form 36 Health 
Survey, COPD Assessment Test score), breathlessness 
(Medical Research Council breathlessness 
scale, Dyspnoea-12), depression (Patient Health 
Questionnaire-9, PHQ-9), anxiety (Generalised Anxiety 
Disorder-7), balance confidence (Activity specific 
Balance Confidence, ABC scale) and physical activity 
(clinical visit PROactive physical activity in COPD tool, 
combining subjective rating and actigraphy).
Results Attendance was 69% overall, (90% of 
the face- to- face sessions, 53% online sessions). 
Analysis of semistructured interviews identified three 
themes regarding participation in SLH delivered 
face to face and online, these where (1) perceived 
benefits; (2) digital barriers (online) and (3) digital 
facilitators (online). Findings were summarised into 
key considerations for optimising transitioning singing 
groups from face- to- face to online delivery. Pilot 
quantitative data suggested possible improvements 
in depression (treatment effect −4.78 PHQ-9 points, 
p<0.05, MCID 5) and balance confidence (treatment 
effect +17.21 ABC scale points, p=0.04, MCID 14.2).
Discussion This study identifies key considerations 
regarding the adaptation of SLH from face- to- face to 
online delivery. Pilot data suggest online group singing 
for people with COPD may deliver benefits related to 
reducing depression and improved balance confidence.
INTRODUCTION
Many people with chronic respiratory disease 
(CRD) remain highly symptomatic despite 
optimal pharmacological treatment. Symp-
toms including exercise limitation, shortness 
of breath and depression are common.1–3 
These can be compounded by social isola-
tion and loneliness, which have been 
shown to be important to respiratory health 
outcomes.4 Group singing is a common prac-
tice in most societies globally and has been 
shown to have health and well- being bene-
fits for people living with long- term health 
conditions and the wider general public.5–7 
There is increasing interest in arts- in- health 
interventions for people with chronic health 
Key messages
What is the key question?
 ► Can Singing for Lung Health (SLH) be delivered on-
line for people with chronic obstructive pulmonary 
disease? And if so, what are the practical issues and 
how does the experience compare with face- to- face 
participation?
What is the bottom line?
 ► SLH appears safe and enjoyable both face to face 
and online. Barriers for online sessions included dig-
ital access and literacy. However, increasing access 
to those previous unable to physically access ses-
sions is also important. In this pilot, depression and 
balance confidence appear to show improvements 
related to participation in an SLH group that transi-
tioned from face- to- face to online delivery.
Why read on?
 ► To our knowledge, this is the first study to assess 
health impacts of online group singing sessions. 
Given the physical distancing measures required by 
the response to COVID-19, there is a need for sing-
ing groups and other similar interventions such as 
pulmonary rehabilitation to be delivered online. This 
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conditions from patients through to government level.8 
Singing for lung health (SLH) is a popular group singing 
programme specifically developed for people with CRD. 
Small scale trials and qualitative studies suggest SLH has 
a range of biopsychosocial benefits for participants,9 10 
however, there is a lack of larger, longer- term, randomised 
controlled trials (RCTs) regarding the impacts of this 
intervention.11 12 The ‘Singing for Health: Improving 
Experiences of Lung Disease (SHIELD) trial’ was setup 
to help to address this gap, planning to randomise 120 
individuals with chronic obstructive pulmonary disease 
(COPD) to participation in 12 weeks of group singing or 
usual care (UC).
During the current COVID-19 pandemic, physical 
distancing measures aimed at reducing SARS- CoV-2 
transmission have led to profound social adaptations 
and disruption.13 Group activities, particularly involving 
people with long- term health problems who are espe-
cially vulnerable to COVID-19, have in most cases been 
suspended, including pulmonary rehabilitation (PR) 
programmes—one of the highest value interventions 
for people with respiratory disease.12 14 Similarly, there 
are particular concerns that group singing could be a 
high- risk activity regarding viral transmission, however 
research is currently limited.15 15
This context has driven interest in the implementa-
tion, and ongoing development, of online approaches 
that attempt to reproduce the social, psychological and 
physical effects of singing, dance and more established 
interventions such as PR.16 17 Such approaches are espe-
cially important for people with lung conditions as even 
prior to the COVID-19 pandemic access to these inter-
ventions was inadequate.18 19 Furthermore, measures 
to reduce risk of COVID-19 in this group appear to 
be causing substantial disruption to care and access to 
health services, with high levels of anxiety and loneliness 
being reported.13 20 21
The first group of participants in the SHIELD trial, 
which began in February 2020, initially met face- to- face 
but the delivery of the intervention changed to an online 
format which is likely to remain necessary for the fore-
seeable future. We decided that this transitional group 
should be reported as a pilot study. This was first because 
research on the health and well- being impacts of online 
singing groups is lacking so the results could guide both 
the further delivery of the SHIELD trial and the design of 
other studies. Second, this would provide useful informa-
tion from individuals who had experience of both face- 
to- face and online activities and could therefore enable a 
comparison of the two types of intervention experience.
METHODS
Trial design and oversight
The SHIELD Trial was prospectively registered at 
ClinicalTrials. gov (NCT04034212). The current anal-
ysis was defined as an amendment to the initial trial 
registration when the delivery of singing moved from 
face to face to online.
Participants
The first group of 18 participants in the SHIELD trial 
were recruited from a specialist COPD clinic at the Royal 
Brompton Hospital London and lists of previous research 
participants who had given consent to be contacted 
regarding research (figure 1). COPD diagnosis was 
confirmed by spirometry as per the Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) guidelines.22 
Exclusion criteria included pulmonary rehabilitation 
within the preceding 4 months. The effects of pulmonary 
rehabilitation tend to wane over time,23 and this interval 
was selected to give a reasonable chance of avoiding the 
most immediate impact of having done PR on study 
measures. We did not include people who would have 
been due to start a PR course within the study period to 
ensure that there were no delays to UC. Further exclu-
sion criteria included an inability to take part in singing 
sessions due to comorbidity (eg, life limiting illness, 
cognitive impairment) and previous participation in SLH 
classes. Given the requirement for the original protocol 
of weekly in- person attendance, from the list of potential 
participants, people living within a 1 hour journey of the 
hospital (estimated using google maps) were contacted 
first. All participants provided written informed consent 
after reading the participant information sheet (PIS) and 
being given the opportunity to ask questions. Transport 
costs related to the assessment visit were reimbursed, but 
no payments were made for participation.
Patient and public involvement
The Royal Brompton Clinical Research Facilities patient 
expert and lay person research panel, and the Royal 
Brompton ‘Breathe Easy’ Group, reviewed the study 
proposal, provided thoughts and suggested improve-
ments which improved the study design and materials 
prior to Research Ethics Committee review. In particular, 
the choice of a quality of life primary outcome measure 
was well received. The Participant Information Sheet 
(PIS) was clarified including reducing use of specialist 
terms and specifying which study- related costs would be 
reimbursed. Overall, the study was very well received by 
these patient and public representatives who saw clear 
value in the patient centred focus of the study.
Interventions
The intervention arm (SLH) received 12, once weekly, 
hour long, SLH sessions. The study control arm received 
UC (no specific additional intervention above those 
which the person usually engages with). The specific 
content and structure of the singing sessions has been 
described elsewhere,10 but briefly, each session consisted 
of a physical warm up, breathing exercises, vocal warms 
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Edmund Jeffery, a professional singing teacher with 
4 years experience leading SLH groups. The SLH 
participants also received a CD of singing exercises and 
were encouraged to practice between sessions, daily if 
possible.
The first five, weekly sessions were delivered face to face 
as originally planned at the Royal Brompton Hospital 
London, UK, and started on the 10 February 2020. These 
were halted due to the developing COVID-19 situation 
in the UK for 2 weeks to develop the online delivery of 
sessions. This process included discussion within the SLH 
provider network regarding suitable content, potential 
barriers and facilitators, and trial sessions with experi-
enced leaders to help address unidentified challenges. 
The online SLH format which was developed was then 
used to deliver the final seven sessions via a video confer-
encing application (Zoom Video Communications, 
‘Zoom’).
Baseline assessment, randomisation and blinding
Assessments took place at the Royal Brompton Hospital 
(London, UK). Following a screening visit, written 
informed consent was taken, followed by a structured 
clinical history, and confirmation of COPD diagnosis 
by spirometry, and baseline assessment of outcome 
measures. Participants were randomised (1:1) using 
computer- generated block randomisation lists (Sealed 
Envelope) block size 4, stratified by Medical Research 
Council (MRC) breathlessness grade and previous 
participation in pulmonary rehabilitation. The outcome 
assessors were blind to intervention allocation. Blinding 
of participants was not possible, and they were informed 
of their allocation by the unblinded researcher respon-
sible for randomisation (SB). Unblinding of assessors 
took place only after all outcome measure data had been 
recorded.
Figure 1 Moving singing for lung health online: experience from a randomised controlled trial: CONSORT diagram. 
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Outcome measures and assessment
Primary outcome measures were change in the Short 
Form 36 Health Survey (SF-36) Physical and Mental 
Component Scores using the oblique scoring method,24 
with subscales provided to aid interpretation. Secondary 
outcomes included change in SF-36 subscales, balance 
confidence (Activity- specific Balance Confidence, ABC 
scale), anxiety (Generalised Anxiety Disorder-7, GAD-7), 
depression (Patient Health Questionnaire-9, PHQ-9), 
COPD assessment test (CAT) score and breathlessness 
(MRC dyspnoea score and Dyspnoea-12). Patient expe-
rience of physical activity was assessed using the clinical 
visit PROactive physical activity in COPD tool (cPPAC). 
The cPPAC combines questionnaire and 7 days of actig-
raphy measures to produce two domains, amount and 
difficulty.25 26 Actigraphy data were collected using the 
Dynaport MoveMonitor (McRoberts BV, The Hague, 
The Netherlands) which is validated for use as part of 
the cPPAC tool. Participants were requested to wear the 
device on a belt around the lumbar region of their back, 
for 7 days, taking it off for showering/bathing. Full guid-
ance on these devices is available from the manufactures 
at https://www. mcroberts. nl/.
The original SHIELD protocol included secondary 
outcome measures of physical capacity and perfor-
mance testing using the 6 minute walk test (6MWT) and 
the short physical performance battery (SPPB), respec-
tively. However, these were only conducted at baseline as 
repeating these measures was not possible due to COVID-
19- related physical distancing measures.
Outcomes measures were repeated after 14 weeks (12 
weeks intervention plus 2- week pause for adaptation of 
delivery after week 5 of intervention). Baseline assess-
ments were completed within 4 weeks prior to the inter-
vention arms first singing session. Follow- up assessments 
were completed within 4 weeks of study completion by 
participants at home, with activity monitors and ques-
tionnaires returned by post. Any missing data (unan-
swered questions) were addressed by telephoning the 
participant. Adverse events were not formally assessed 
as an outcome, but participants were advised to inform 
the session leaders if they become unwell or had any 
concerns.
Qualitative data
Semistructured qualitative feedback interviews were 
conducted on the phone (by KEJP who has training and 
experience in qualitative research techniques) with the 
SLH participants following unblinding of researchers. 
Interviews focused on overall experience of interven-
tion, positives, negatives and barriers and facilitators to 
participation (as covered with an approved amendment 
to the Research Ethics Committee application). Notes 
were made during the call and a template response form 
was completed immediately after each call to record 
participant responses and interviewer reflections. Audio 
recordings of the interviews were not made. Primarily 
deductive thematic analysis was used27 in which initial 
codes were developed around barriers, facilitators and 
perceived impacts of participation, using a combination 
of biopsychosocial28 and randomised pilot study concep-
tual frameworks.29 Comparison of experiences of face- to- 
face and online groups was also sought.
Statistical analysis
The power calculation for the original SHIELD trial 
required 120 participants to show a clinically important 
difference in the primary outcome (SF-36). Given the 
circumstances, no power calculation was performed for 
this revised pilot study. Differences in outcomes between 
study arms were evaluated using one- tailed t- tests for 
superiority of SLH over UC or the Wilcoxon rank- sum 
(WRS) test where data were not normally distributed. 
Analyses were carried out using Stata V.14 (StataCorp) 
on an intention- to- treat basis.
Data shown are mean (SD), or if appropriate, median 
(IQR)/number (%) as indicated. P values are for t tests 
for between groups differences, or WRS as marked, 
if appropriate. Body mass index; 6 min walk distance, 
6MWT distance; SPPB; prestudy perception of SLH 
impact, participants asked to rate on scale of 0–10 
expected impact of singing on improving health with 0 
is no impact, and 10 very large improvement in health; 
SF-16; PHQ-9; GAD-7 questionnaire; ABC score, Activity 
specific Balance Confidence scale; MRC; CAT; PROac-
tive, Patient Reported Outcome measure for physical 
activity in COPD.
RESULTS
The intervention and control groups were well- matched 
at baseline (table 1). No serious adverse events were 
reported by study participants, though these were not 
sought systematically. No participants withdrew from the 
study. However, difficulties with attendance at the online 
sessions is described below. Use of the CD for practice 
between sessions was not formally quantified, however, 
participants reported very variable use, from not at all to 
daily. Summaries are provided regarding considerations 
(table 2), and practical issues (table 3), relating to tran-
sitioning from online versus face- to- face delivery of SLH, 
based on participant and facilitator experiences.
Attendance
For the SLH arm, mean number of sessions attended 
was 8.4 (69%) of the 12 total sessions. This included a 
mean of 4.5 (90%) of the five face- to- face sessions, and 
3.7 (53%) of 7 online sessions. Three of the participants 
did not attend the online sessions at all, three attended 
all seven sessions, with the remaining three partici-
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Effect on intervention
Mean difference from baseline was compared between 
the control and SLH groups in table 4 using t- tests, or 
WRS tests as appropriate. These outcomes are presented 
for information, but cannot, of course, be used to make 
any confident inference about the effectiveness or other-
wise of the intervention given the limited sample size and 
lack of statistical power. Comparing singers with non- 
singers there were statistically significant improvements 
in the PHQ-9 depression score (treatment effect −4.78 
Table 1 Baseline characteristics
Singing for lung health
(SLH) (n=9) Usual care (n=9) P value
Age 72.1 (9.65) 69.89 (9.36) 0.63
Female 3 (33%) 6 (66%) 0.18
BMI 23.30 (7.20) 25.52 (6.41) 0.50
FEV1 % predicted 56.39 (35.57) 35.01 (17.84) 0.13
Oxygen therapy 1 (11%) 2 (22%) 0.60
Pack years smoked 36.23 (19.95) 41.89 (31.26) 0.66
Falls in last year 1 (11%) 1 (11%) 1.00
Baseline 6MWD 418 (136.23) 366 (82.30) 0.34
SPPB total 9.56 (2.19) 9.11 (2.32) 0.68
Prestudy expectation of SLH health 
impact
(0 ‘no impact’ to 10 ‘large impact’)
4.56 (1.33) 4.56 (2.24) 1.00
SF-36 Physical Component Score 39.11 (8.39) 34.91 (8.26) 0.30
SF-36 Mental Component Score 45.76 (4.60) 41.52 (35.16) 0.20
SF-36 Physical function 43.89 (26.43) 36.67 (27.95) 0.58
SF-36 Role limitation, physical 50.00 (41.46) 25.00 (39.53) 0.21
SF-36 Role limitation, emotional 85.19 (24.22) 62.97 (35.14) 0.14
SF-36 energy 40.56 (17.40) 42.23 (18.05) 0.84
SF-36 emotional well being 74.67 (11.66) 66.23 (14.44) 0.19
SF-36 social functioning 79.17 (20.73) 61.11 (34.60) 0.20
SF-36 pain 65.56 (21.71) 61.39 (29.77) 0.74
SF36 general health 32.22 (13.94) 31.11 (14.95) 0.87
SF-36 health change 47.22 (19.54) 52.78 (23.20) 0.59
Depression (PHQ-9) 5.00 median (IQR 3.00–8.00) 6.00 median (IQR 5.00–14.00) 0.28 (WRS)
Anxiety (GAD-7) 2.00 median (IQR 1.00–2.00) 5.00 median (IQR 0.00–11.00) 0.23 (WRS)
ABC scale score 78.75 median (IQR 50.63–90.63) 76.25 median (IQR 64.38–91.25) 0.72 (WRS)
Dyspnoea 12 11.00 median (IQR 7.00–15.00) 13.00 median (IQR 8.00–20.00) 0.27 (WRS)
MRC dyspnoea score 2.89 (0.93) 3.00 (1.32) 0.84
CAT score 18.11 (7.10) 21.00 (7.57) 0.42
PROactive difficulty* 68.56 (13.28) 63.11 (14.60) 0.42
PROactive amount† 53.67 (14.14) 46.67 (18.21) 0.38
PROactive total‡ 61.11 (12.06) 54.89 (13.86) 0.32
Daily step count 2717 median (IQR 1870–4871) 2566 median (IQR 1213–3119) 0.40 (WRS)
Data shown are mean (SD), or if appropriate, median (IQR)/number (%) as indicated. P values are for ttests for between 
groups differences, or Wilcoxon rank- sum (WRS) as marked, if appropriate.
*Scale of 0 (high level difficulty) to 100 (low level of difficulty).
†Scale of 0 (low amount) to 100 high amount.
‡Total score calculated as mean of PROactive difficulty and PROactive amount (0–100).
ABC, Activity specific Balance Confidence; BMI, body mass index; CAT, COPD Assessment Test; FEV1, forced expiratory 
volume in 1 s; GAD-7, Generalised Anxiety Disorder-7; MRC, Medical Research Council; 6MWD, 6 min walk distance; PHQ-9, 
Patient Health Questionnaire-9; PROactive, Patient Reported Outcome measure forphysical activity in COPD; SF-36, Short 
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points, p=0.049, Minimum Clinically Important Differ-
ence (MCID) 5) and ABC scale for balance confidence 
(treatment effect +17.21 points, p=0.038, MCID 14.2).
Participant experience
Eight of the nine SLH participants were interviewed by 
phone, one was not available. Deductive analysis identi-






All SLH participants reported greatly enjoying participation 
while session delivery was face to face. The online sessions 
were enjoyed by the majority of participants, though all 
stated an overall preference for face- to- face sessions. This 
preference related primarily to the social environment 
and interpersonal interactions. Participants spoke fondly 
of their interactions with each other when face to face but 
highlighted that this was more difficult to achieve online. 
Participants emphasised that these social aspects were 
particularly important due to the social distancing meas-
ures that had been put in place due to COVID-19. It was 
frequently remarked on that the sessions provided an 
important connection to the ‘outside world’. Participants 
reported it ‘helps your breathing’ and that ‘Certainly my 
breathing is better now than before’ especially due to 
breathing control exercises and techniques. Improvements 
in mood and enjoyment of the social aspects were frequently 
reported. There was also a perception that the singing had 
contributed to other types of physical activity ‘the singing 
has contributed to my exercise levels’. Such benefits were 
seen as important due to their relevance to symptoms of 
their lung condition.
Digital barriers
Barriers relating to online delivery mostly related to tech-
nical difficulties. The majority experienced some form of 
technical difficulties; only those who reported regularly 
(weekly or more), and independently, using online confer-
encing tools had no issues. Of those that did not attend at 
all online, one did not have a computer and one did not 
have a functioning internet connection. The third partici-
pant who did not participate online chose not to as they felt 
making noise would not be considerate to their neighbours, 
given the limited sound insulation, and ongoing ‘lockdown’ 
measures for all the residents of his building. Some partic-
ipants were able to ask friends or family members to help 
Table 2 Considerations for online versus face- to- face delivery of singing for lung health (SLH) based on participant and 
facilitator experience
Face to face Online
Access: Physical More challenging
Geographically local SLH sessions
Transport requirement
Financial and time costs
Availability and accessibility in context of 
lung condition and symptoms.
Private physical space still required for participant.
Access: Online Limited or no requirement
Can be used for session organisation.
Computer/device and internet access required.
Overcomes multiple face- to- face physical barriers.
Digital literacy Not required Required
With support can be minimal
Could help build skills/confidence facilitating 
access to other online services.
Infection/health risks Potential risk of cross infection from 
participants or infection during transport to/
from session.
Not supervised in person
Contact details of next- of- kin advisable for 
potential issues.
Social experience Very effective and important to participants. Good (perhaps less than face to face)
Building rapport more challenging, especially if 
have never met in person (new groups/individuals)
Specific content to address advised.
Personal experience Presence of peers can be both supportive 
and slightly intimidating depending on 
individual and group dynamic.
The required technological skills can induce mild 
anxiety if participant not confident/experienced.
Physical engagement Important aspect of session
Journey to/from session also valuable 
physical activity for some.
More challenging than face to face
Requires specific consideration and promotion.
Facilitator experience Easier to gauge participant emotions and 
group dynamic.
More challenging to assess if appropriate 
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with overcoming technological challenges, which worked 
well. However due to the ‘lock- down’ and social shielding, 
this was not possible for all the participants. Some of the 
technological difficulties experienced by participants 
appeared potentially addressable with appropriate support. 
However, some participants seemed unconfident in trying 
to address them. A lack of confidence trouble- shooting tech-
nological challenges is likely to have consequences beyond 
these sessions by limiting access to digital health and social 
resources more generally. As such, supporting digital access 
in this context could be a useful way to build digital literacy 
and confidence.
Online delivery was also felt to be less personal, as 
interaction between participants was more challenging 
‘meeting at the Brompton was much more engaging. It’s 
so nice to sing together as a group’. One participant stated 
that ‘Physically demanding things are better done in a 
group’, with group motivation more palpable in person 
than online. The extent to which this preference for 
face- to- face interaction was modulated by the COVID-19- 
related social distancing measures and fear for personal 
safety13 is difficult to tell. It is possible that the relative, or 
even complete, absence of face- to- face interaction in any 
aspects of the participants lives during the ‘lockdown’ 
heightened the value that they attributed to the face- to- 
face singing sessions they attended at the beginning of 
the study. Even though face to face was preferred, online 
delivery was still seen as being extremely valuable ‘Even 
online, it’s an up- lifting thing to do for mental health. We 
spent quite a lot of time laughing. Singing as a group is 
special.’ Other aspects of the sessions were also noted to 
be lost when adapting the sessions to online. For example 
‘singing in canon (a compositional technique in music)’, 
which was thoroughly enjoyed in person, were not tech-
nically possible during sessions delivered online.
It was felt that by having started the sessions face to face 
a degree of rapport had been built between participants, 
and with the singing leader, that helped with the transi-
tion online. It was suggested that it might be more difficult 
to establish rapport between group members if groups 
commenced online with no prior meeting in person.
Digital facilitators
On certain points, online delivery was perceived as having 
benefits over in person sessions. One participant high-
lighted that ease of attendance enabled them to attend 
when they were not feeling 100% well and would not have 
attended in person had they needed to physically transport 
themselves to the singing session. Another participant felt 
that by being online they were less self- conscious singing 
with the other participants as they would not be able to hear 
the participant’s voice. Multiple participants highlighted 
Table 3 Practical issues transferring face to face to online based on participant and facilitators experience
Informing participants People are generally understanding of current requirement for physically distanced sessions.
Joining online Participants may need support with digital access.
Friends and family a good source of support.
Dedicated ‘set up sessions’ could help in which session leader talks the participant through setting 
up, 1 to 1, separately and in advance of the SLH session.
Physical space Clean, tidy and free from trip hazards.
Sound Speakers advisable for better volume and sound quality
Feedback Integration of formal feedback vital to facilitate responsive and participant appropriate sessions.







Session content Cannon and multi- harmonies (live)—difficult.
Prerecorded content to facilitate multipart songs possible, but complicated.
Focusing on what works best in each method of delivery more important than trying to exactly 
emulate face- to- face sessions online.
Discussion between singing leaders using similar participant groups and swapping ‘best practice’ 
from experience works well.
Keep up to date The evidence base is in this area is evolving, so ongoing review of relevant research and guidelines 
is important, including related activities such as pulmonary rehabilitation.38
Safety Ensure contact details are correct.
Asking participants to provide next of kin details can be useful.
Ensure participants take breaks or stop if feeling unwell in any way.
Clear space, free from trip hazards important for participants.
Ethical Issues Participants should consent to any use of their personal data.
Closed/password- protected online sessions important to prevent uninvited interruptions.
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that online delivery overcame many of the barriers related 
to physically accessing face- to- face participation including 
geographical location of sessions, using transport with high 
symptoms burden, and current infection risks.
DISCUSSION
To our knowledge, this is the first study to assess the prac-
tical delivery of an online group singing intervention 
for people with respiratory disease intended to improve 
health and well- being. This transition from face- to- face 
to online delivery was forced on us by the COVID-19 
pandemic, but provides useful information about how 
this can be done and allowed us to gain insights from 
people who had experienced both formats of delivery.
Key findings include that SLH delivered online was 
viewed as enjoyable and holistically beneficial to health, 
though face to face was generally preferred. Importantly, the 
perceived benefits were directly related to moderating their 
lung condition symptoms. The psychosocial impacts were 
highly valued by participants, but more difficult to achieve 
in the online format. Technological difficulties prevented 
some people from participation in online sessions, which 
were also felt to be less personal as social interaction was 
more challenging. The pilot data suggest that group singing 
for people with COPD, adapted to online delivery, may 
still deliver benefits related to reducing depression and 
improved balance confidence.
These findings are broadly supportive of other 
related studies. However, these findings should be inter-
preted within the context of COVID-19- related physical 
distancing and ‘shielding’ measures. In a small (n=28) 
RCT of a 6- week course of twice weekly face- to- face SLH, 
Lord et al30 found psychological improvements, though 
these related to anxiety rather than depression, and 
qualitative research has reported similar findings to the 
current study in relation to perceived impact on health 
and wellbeing.31 Qualitative research from a dance group 
for people with CRD and breathlessness also identified 
perceived holistic benefits with an emphasis on psychoso-
cial impacts (KEJP Dance qual). Previous studies on SLH 
Table 4 Comparison of change in outcome measures between study arms
Singing for lung health 
(SLH) (n=9) Usual care (UC) (n=9)
Treatment effect
(95% CI) P value
SF-36 Physical Component Score −1.66 −0.389 −1.27 (−7.13 to +4.60) 0.67
SF-36 Mental Component Score −0.367 −4.30 +3.93 (−3.85 to +11.72) 0.15
SF-36 Physical function −1.11 2.77 −3.89 (−14.02 to +6.24) 0.79
SF-36 Role limitation, physical −16.67 −2.78 −13.89 (−42.44 to +14.66) 0.84
SF-36 Role limitation, emotional −7.41 −33.33 +25.92 (−14.51 to +66.35) 0.10
SF-36 energy 6.11 −1.11 +7.22 (−9.59 to +24.03) 0.19
SF-36 emotional well- being 2.22 −6.22 +8.44 (−7.62 to +24.51) 0.14
SF-36 social functioning −6.95 −15.28 +8.33 (−18.85 to +35.52) 0.26
SF-36 pain 0.28 5.78 −5.50 (+29.57 to +18.57) 0.68
SF-36 general health 0 1.67 −1.67 (−12.98 to +9.65) 0.62
SF-36 health change over last year 5.56 −13.89 +19.44 (−0.09 to +38.97) 0.026
Depression (PHQ-9) −1.44 +3.33 −4.78 (−10.53 to +0.98) <0.05
Anxiety (Median (IQR)) 0.00 (0.00 to 1.00) 2.00 (0.00 to 3.00) 2.00 0.24
ABC scale score 6.03 −11.18 +17.21 (−2.07 to +36.49) 0.04
Dyspnoea 12 −0.445 0.445 −0.89 (−7.69 to +5.91) 0.39
MRC dyspnoea score 0.222 0.111 +0.11 (−0.61 to +0.84) 0.63
CAT score −1.44 2.22 −3.67 (−9.42 to +2.08) 0.10
PROactive Difficulty* 0.889 −1.12 +2.00 (−9.78 to +13.79) 0.362
PROactive amount† −20.22 −6.89 −13.33 (−30.07 to +3.41) 0.95
PROactive total‡ −9.67 −4.00 −5.67 (−13.68 to +2.35) 0.92
Daily step count (median IQR)) −531 (–823–-65) −372 (−1123–150) −159 0.76
P values are one- tailed independent sample t- tests of mean change preintervention–postintervention, for superiority of SLH over UC, or 
Wilcoxon rank- sum test if non- parametric test required, with median (IQR) shown.
*Change in the scale of 0 (high level difficulty) to 100 (low level of difficulty);.
†Change in the scale of 0 (low amount) to 100 high amount.
‡Change in the scale of the total score calculated as mean of PROactive difficulty and PROactive amount (0–100). MCID for the PHQ-9 is 5 
points39; MCID for ABC score is 14.2 points.40
ABC, Activity specific Balance Confidence; CAT, COPD Assessment Test; MRC, Medical Research Council; PHQ-9, Patient Health 


















es: first published as 10.1136/bm






Philip KEJ, et al. BMJ Open Resp Res 2020;7:e000737. doi:10.1136/bmjresp-2020-000737 9
Open access
for people with COPD have suggested improvements in 
quality of life,30 32 33 which was not seen here, though it is 
not clear if this was due to the small sample size. Further-
more, our findings echo those of a study comparing the 
experiences of participants in a virtual choir with those 
in a live choir, which found the two types of experience 
provide very similar emotional benefits, though differ-
ences in how ‘present’ participants felt.34
The qualitative data identified specific barriers and 
facilitators related to the different formats of delivery, 
which helps to explain the attendance data. The consort 
diagram highlights that many (n=23) potential partic-
ipants declined due to issues with physically accessing 
the face- to- face sessions, mainly related to viewing public 
transport as too challenging given their health condition. 
However, online delivery demonstrated good potential 
to overcome physical distance as a barrier to access. As 
highlighted in the interview feedback, during the online 
section of the study, there were days when individuals 
participated but felt they would not have felt well enough 
to come in person if the sessions were still being held 
at the hospital. Regarding the online sessions, difficulties 
with digital literacy and digital access presented barriers, 
in some cases preventing ongoing participation in those 
who stated they deeply enjoyed the face- to- face sessions.
The consort diagram may have been different if the 
methods of delivery had been known from the start. Some 
people who declined participation due to difficulties 
physically accessing the hospital may have participated. 
However, those for whom digital delivery poses barriers 
may have declined. Clearly digital access is a vital consid-
eration to address to overcome this potential barrier to 
participation. Additionally, participant rapport building 
appears to be an area requiring particular consideration.
Some limitations to this study are important to discuss. 
First, the need for rapid adaptation of study delivery 
meant that the methods for supporting singing online 
had not been refined. That said, it has provided a 
unique opportunity to gain insights into the transition 
from face- to- face to online delivery which has, by neces-
sity, become widespread. Second, given the novelty of 
the online delivery, the session content and technical 
considerations are likely to develop over time with expe-
rience, which could alter the relevance of the current 
findings to future sessions. However, this is not neces-
sarily a weakness, as the current findings provide useful 
results on which to base these developments. Third, the 
sample size was small due to the circumstances in which 
it was decided to evaluate this group and because the 
mode of delivery changed part- way through. This limits 
the confidence in quantitative impacts, and means it is 
unclear whether singers experienced benefits during the 
face- to- face or online part of the programme, or a combi-
nation of the two. Nevertheless, as a convenience pilot 
study, it provides useful indications of impacts, as well 
as informing future research. Similarly, the suboptimal 
attendance during online sessions limits the extent to 
which impact can be assessed, although when combined 
with the interview feedback this provides useful infor-
mation regarding barriers and facilitators to participa-
tion that can be addressed in both practice and future 
research. See tables 2 and 3 for suggestions. Finally, it is 
important to consider the context in which this trial took 
place. The developing COVID-19 pandemic was a consid-
erable source of concern for many people with COPD, 
who were identified as being at an increased risk of severe 
COVID-19 or death. Though all the participants lived in 
London, the situation and their response to it, is likely 
to have differed between individuals, which intern, may 
have shaped their experience of the intervention.
Despite the necessary, yet unusual, adaptations to the 
methods, this study has provided interesting and poten-
tially useful results to inform the development of further 
research regarding online singing group delivery and 
research. These findings are useful for existing SLH 
groups who are moving to online delivery of previously 
in- person sessions. They also provide some of the first 
research findings to support the delivery of participa-
tory online arts- in- health interventions in the context of 
COVID-19- related physical distancing.
The findings may also provide relevant insight for 
other related activities making an online transition such 
as pulmonary rehabilitation and Tai- Chi,35 and dance for 
people with long- term medical conditions. Many of these 
activities had begun to develop and test online delivery 
approaches prior to the COVID-19 pandemic,36 37 though 
the importance and potential utility of online delivery 
has now clearly increased.17
Further research should include larger studies assessing 
the health and well- being impact of online group singing 
in patient groups and for the wider population. Larger 
studies of SLH specifically, both online, and face- to- face 
(when appropriate to do so) remain a priority. Even 
after the acute phase of the COVID-19 pandemic online 
delivery of singing groups presents an opportunity to 
widen access to certain groups of people. In- depth qual-
itative research exploring participant experience would 
also be valuable, and in particular, in what ways the wider 
context of physical distancing measures impacts the 
experience of in person or online singing sessions.
CONCLUSIONS
In conclusion, this study suggests that group singing 
sessions that have had to change delivery from face- to- 
face to online may produce clinically significant impacts 
on depression scores and improve balance confidence 
in people with COPD. The findings also identify impor-
tant differences between online and face- to- face delivery 
including technological barriers for online delivery, 
and overcoming physical access barriers to face- to- face 
delivery. Despite a general preference for face- to- face 
sessions, online delivery was still felt to provide substan-
tial health and well- being benefits. Future research on 
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